<?xml version="1.0" encoding="UTF-8"?>
<ref id="B8-vaccines-07-00203">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Noble</surname>
    <given-names>C.G.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Y.-L.</given-names>
   </name>
   <name>
    <surname>Dong</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Gu</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Lim</surname>
    <given-names>S.P.</given-names>
   </name>
   <name>
    <surname>Schul</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Q.-Y.</given-names>
   </name>
   <name>
    <surname>Shi</surname>
    <given-names>P.-Y.</given-names>
   </name>
  </person-group>
  <article-title>Strategies for development of dengue virus inhibitors</article-title>
  <source>Antiviral Res.</source>
  <year>2010</year>
  <volume>85</volume>
  <fpage>450</fpage>
  <lpage>462</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2009.12.011</pub-id>
  <pub-id pub-id-type="pmid">20060421</pub-id>
 </element-citation>
</ref>
